Raybow USA Inc., the North American unit of a global provider of outsourced pharmaceutical process development and manufacturing services, will expand its operations in North Carolina, tripling both its capacity and workforce. The company plans to add 74 jobs over the coming five years and will invest $15.8 million at the Brevard facility.
 
Raybow USA was founded as PharmAgra Labs in 1999 by two North Carolina entrepreneurs. Today, the Brevard-based company is the North American unit of China’s Raybow Pharmaceuticals, a publicly-held CDMO that partners with leading pharmaceutical companies across Asia, Europe and North America.
 
Raybow USA, which currently employs 24 in Brevard, focuses on early-stage R&D and process research through Phase II clinical trials.
 
“Raybow Pharmaceuticals is proud to announce that, a year since we acquired the Brevard site, we are ready to further increase our commitment in North Carolina,” said Peter Halkjaer-Knudsen, executive vice president, Raybow Pharmaceuticals. “We are grateful for the warm welcome we have received and the continued support we experienced during the feasibility studies for this expansion. Transylvania County has proven to be the right choice for our North American headquarters and R&D operations and we very much look forward to the continued journey with the people of North Carolina.”
 
New positions at Raybow USA will include research chemists, pilot-plant personnel and supervisors.